Has Corbin Jacobs, MD received payments from drug or device companies?

Yes. Drug and device makers reported $806 in general payments to Corbin Jacobs, MD across 9 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Corbin Jacobs, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Corbin Jacobs, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Corbin Jacobs, MD

Radiation Oncology · Post Falls, IDNPI 1982099412

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $525 of the $806 with a category attached, or 65.1%. AstraZeneca accounts for 65.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $525 and has fallen 78.6% since, to $112 in 2025.

$806in general payments, 2019–2025

Across 9 payments — averaging $89.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$525
Reflexion Medical, Inc.$116
Elekta, Inc.$47
AbbVie$28
Progenics Pharmaceuticals, Inc.$25
Merck$25
plus $40 from 3 others

What the payments were for

Consulting fees$52565%
Food & beverage$28135%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	1	$525
Reflexion Medical, Inc.	1	$116
Elekta, Inc.	1	$47
AbbVie	1	$28
Progenics Pharmaceuticals, Inc.	1	$25
Merck	1	$25
Pfizer	1	$20
Sumitomo Pharma America, Inc.	1	$15
Ambu Inc.	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

IMFINZI$525
REFLEXION MEDICAL RADIOTHERAPY SYSTEM$116

How this compares

$806 in reported general payments places this provider in the 60th percentile of 22 radiation oncology providers in Idaho.

See all radiation oncology providers in Idaho →

Medicare billing

Part B allowed, 2024

$890,228

Medicare patients

282

Services billed

4,197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	62	$888
Oxycodone Hcl	24	$602
Omeprazole	21	$233
Oxybutynin Chloride ErOxybutynin Chloride	11	$223
Dexamethasone	11	$209
Fluconazole	13	$196
Pantoprazole Sodium	18	$195
SsdSilver Sulfadiazine	11	$87
Ondansetron OdtOndansetron	11	$84
Prednisone	14	$54

Paid to pharmacies, not to this prescriber.